INNOGENE Co., Ltd. Logo

INNOGENE Co., Ltd.

Develops and distributes anti-aging products for skin regeneration and hair health.

344860 | KO

Overview

Corporate Details

ISIN(s):
KR7344860002
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로33길 28, 301호, 서울특별시

Description

INNOGENE Co., Ltd. is a company specializing in anti-aging solutions. It develops, manufactures, and distributes advanced therapeutic products and cosmetics focused on skin regeneration and hair follicle health. The company's research and development leverages core technologies in medical informatics and a stem cell database to create its product portfolio. These solutions are designed to address concerns related to skin aging and hair loss, based on scientific studies of stem cell applications and healthy beauty.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-13 00:00
[기재정정]주주총회소집공고
Korean 184.1 KB
2023-03-10 00:00
주주총회소집공고
Korean 181.3 KB
2023-03-08 00:00
감사보고서제출
Korean 17.4 KB
2023-02-24 00:00
주주총회소집결의
Korean 11.8 KB
2023-02-23 00:00
주식등의대량보유상황보고서(약식)
Korean 104.0 KB
2023-02-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.4 KB
2023-02-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.3 KB
2023-02-23 00:00
[기재정정]주식등의대량보유상황보고서(약식)
Korean 106.0 KB
2023-02-23 00:00
주식등의대량보유상황보고서(약식)
Korean 72.5 KB
2023-02-22 00:00
주식등의대량보유상황보고서(일반)
Korean 88.9 KB
2023-02-14 00:00
증권발행결과(자율공시)(일반공모 유상증자)
Korean 5.8 KB
2023-02-14 00:00
상장폐지결정(코스닥시장 이전상장)
Korean 8.9 KB
2023-02-14 00:00
증권발행실적보고서
Korean 123.4 KB
2023-02-10 00:00
유상증자또는주식관련사채등의청약결과(자율공시)(일반공모 유상증자)
Korean 7.9 KB
2023-02-08 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 129.2 KB

Automate Your Workflow. Get a real-time feed of all INNOGENE Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for INNOGENE Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for INNOGENE Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.